Articles tagged with Neurodegenerative Diseases
A groundbreaking clinical trial has shown that gene therapy can halt the progression of spastic paraplegia type 50 (SPG50) in a young boy. The treatment, delivered via spinal fluid, eliminated serious side effects and showed potential signs of improvement.
A team of researchers will study the effects of TBI on neurodegeneration to gain insight into ADRD development. They aim to uncover the underlying biological mechanisms and identify factors that increase the risk of ADRD.
Researchers from PSI and ETH Zurich studied connexin-36 gap junction channels and found that antimalarial drug mefloquine binds to the channels, potentially explaining its severe side effects. The study provides new insights into how drugs interact with connexins and may lead to the development of therapies for neurological diseases.
Researchers at Colorado State University used human stem cells to study synaptic connections in the brain, focusing on GABAergic synapses. They found that Gephyrin promotes autonomous assembly of these synapses, which can develop independently of neuronal communication. This understanding could lead to new treatments for neurological d...
A landmark clinical trial collaboration has reported significant improvements in neurobehavioral and functional outcomes for children with moderate to advanced stages of Sanfilippo syndrome. The study found anakinra, a recombinant interleukin-1 receptor antagonist, to be safe and effective in reducing disease symptoms.
A study by TUM researchers discovered four subtypes of Amyotrophic Lateral Sclerosis (ALS) with different molecular processes, including sex differences. The findings suggest repurposing an approved cancer drug targeting the MAPK pathway as a promising therapeutic approach for ALS.
Researchers found that men taking terazosin-type medications had about a 40% lower risk of developing dementia with Lewy bodies compared to those taking tamsulosin or 5-alpha reductase inhibitors. The study suggests that these drugs may have broad potential for treating neurodegenerative conditions.
Dorothee Dormann and Edward Lemke propose a new concept to measure the individual risk of getting age-related diseases by analyzing protein clumps in cells. This 'protein aggregation clock' could help diagnose age-related diseases at early stages or identify people at higher risk.
Researchers developed an AI-based screening tool that differentiates Alzheimer's disease and Lewy body disease by analyzing eye movement patterns. The tool provides a reliable method for identifying and distinguishing between the two dementia forms, which can aid in mitigating their impact on daily activities.
A new AI-driven tool can accurately diagnose Lewy body dementia by analyzing changes in vocal emotional expressions. The study found that individuals with Lewy body dementia exhibited more negative and calmer emotional expressions compared to those with Alzheimer's disease and healthy controls.
Researchers at the University of Rochester Medical Center found that ketones can rescue impaired neuronal function in the hippocampal network. This study suggests a potential therapeutic approach for preventing or delaying neurodegenerative diseases like Alzheimer's.
Researchers have developed a new mathematical tool to study cell protein degradation rates, which helps understand cell growth, death, and aging. The study found that not all proteins degrade at the same pace, with some breaking down in minutes, hours, or days.
Researchers developed a new system to prevent dementia, which was tested on 30 volunteers with mild cognitive impairment. The system showed a significant reduction in cognitive impairments after six weeks of training.
Researchers have discovered a small molecule compound called ESI1 that can regenerate vital myelin coatings, potentially treating multiple sclerosis and age-related cognitive deficits. The treatment promotes healing by clearing a roadblock in the repair process, allowing oligodendrocytes to produce myelin sheaths.
Scientists identify ZIP7 as a key player in reducing ER stress, which is responsible for misfolded protein accumulation. Overexpressing ZIP7 restores cell mobility, suggesting its potential as a therapy target for degenerative diseases.
Researchers identify TRMT10C enzyme causing methylation of ND5 mRNA, leading to mitochondrial dysfunction and reduced energy supply to the brain. Impairment of complex I in the respiratory chain contributes to Alzheimer's disease pathology.
Researchers have developed a magnetic coil array called MagPatch that can stimulate individual neurons with precision. The device uses soft magnetic materials to boost the magnetic field, reducing the need for high current levels.
Researchers used machine learning to analyze over 1.09 million potential metabolite-receptor pairs and predict the likelihood that each interaction contributed to Alzheimer's disease. The study found a protective metabolite called agmatine interacting with a receptor called CA3R in brain cells, reducing CA3R levels and lowering phospho...
Depletion of axonal mitochondria disrupts autophagy, leading to abnormal protein build-up in neurons. Restoring mitochondrial levels restores autophagy and recovers impaired neuron function.
Researchers at Gladstone Institutes have identified a blood coagulation protein, fibrin, as the culprit behind toxic inflammation and neuron loss after a major head injury. This finding can inform new treatment strategies for traumatic brain injuries, which often lead to dementia, depression, and difficulty concentrating.
Emerging from a need to understand organelle interactions, researchers have developed OrthoID, a novel strategy that refines protein identification at organelle contact sites. This method uses mutually orthogonal binding pairs to label and isolate proteins involved in cellular communication.
Researchers found a significant association between storing chemicals in attached garages and increased ALS risk. The study suggests that volatile chemicals released into the living space may contribute to this link.
Air pollution exposures are linked to increased risk of neurodegenerative diseases such as Alzheimer's and Parkinson's. The new PM2.5 standard may not be sufficient to mitigate these risks, especially for vulnerable populations.
Researchers discovered that mature oligodendrocytes, critical for brain function, can survive for up to 45 days after a fatal trauma, defying the classical programmed cell-death pathway. This finding opens new avenues for understanding and potentially preventing damage caused by aging and neurodegenerative diseases.
McGill researchers have made a groundbreaking discovery about Spinocerebellar ataxia type 6, a rare and devastating neurodegenerative disease. Damaged mitochondria in the cerebellum are found to contribute to disease progression.
A study using a xenotransplantation model has revealed that human microglia respond to amyloid-β plaques with a complex immune response, influencing the disease course. The research highlights the importance of considering genetic factors in microglia-targeted therapies for Alzheimer's disease.
Researchers have identified PDE4B as a potential target for treating Alzheimer's disease, where reducing its activity shows promise in improving memory and glucose metabolism. The study suggests that this approach may also protect against other forms of dementia, such as Huntington's disease.
Rats consuming reheated sesame or sunflower oil showed increased oxidative stress and inflammation in the liver, leading to significant damage in the colon and changes in endotoxins. The study suggests that long-term deep-fried oil consumption may contribute to neurodegeneration and highlight the need for further research on this topic.
A recent study published in Cell reveals significant similarities between amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD), two distinct neurological disorders. The research found shared gene expression patterns across various brain regions, suggesting potential therapeutic targets for both conditions.
Researchers at University of Pittsburgh are developing a platform to genetically modify glia cells using bioengineering modified RNAs. The goal is to increase or decrease disease-relevant genes in astrocytes or microglia to potentially treat Alzheimer's disease and other neurodegenerative disorders.
A clinical trial at NIH demonstrated that experimental gene therapy slowed loss of motor function in patients with giant axonal neuropathy, a fatal childhood disease. The treatment also showed signs of regeneration in sensory nerves, offering new hope for those affected.
The American Society for Biochemistry and Molecular Biology's annual meeting features exciting research findings on antibacterial compounds, whooping cough infection, nicotine addiction, and more. Complementary on-site press passes will be issued to a limited number of attendees.
Researchers at the University of Bergen have identified a new gene linked to primary familial brain calcification (PFBC), a rare neurodegenerative condition. The discovery provides new insight into how brain calcifications occur and may help explain the development of dementia.
A first-of-its-kind study uses gait analysis to detect subtle impairments in older adults with mild cognitive impairment, suggesting curved path walking as a more sensitive detection method. The novel system employs a non-invasive depth camera to record gait and provides detailed information on functional performance.
Researchers have discovered why some RNA-splicing drugs work better than others, revealing a key factor that impacts treatment efficacy. By analyzing the interactions between drugs and RNA, they found that combining splice-modifying drugs targeting the same gene segment can lead to greater therapeutic effects.
A new study led by Cleveland Clinic researchers suggests that sildenafil may help protect brain cells from Alzheimer's disease. The study found that sildenafil can lower levels of neurotoxic tau proteins and improve brain function in patients with Alzheimer's.
Researchers will develop new tools to understand how proteins interact and regulate the nervous system. The project aims to identify new therapeutic targets for brain disorders and generate diagnostic tools.
A study published in Cancer Research Communications reveals a potential genetic marker associated with better survival outcomes in patients with head and neck cancer. The researchers found that the presence of a specific genetic variant and higher expression of the GAN gene product gigaxonin may contribute to improved survival rates.
A study published in BMC Geriatrics uses in-vehicle sensors to detect anomalous driving behavior indicative of cognitive impairment in older adults. The system analyzes driving patterns, facial expressions, and eye movement to identify early signs of dementia.
Researchers at Salk Institute have created a novel organoid model of the human brain that includes mature, functional astrocytes. This allows for the study of inflammation and stress in aging and diseases like Alzheimer's with greater clarity, revealing a relationship between astrocyte dysfunction and inflammation.
Researchers at MIT's Picower Institute found that stimulating a key brain rhythm with light and sound increases peptide release from interneurons, driving clearance of Alzheimer's protein. The study suggests that 40Hz sensory stimulation promotes increased amyloid clearance via the glymphatic system.
Scientists at Washington University School of Medicine discovered that neurons coordinate to produce rhythmic waves that propel fluid through dense brain tissue, washing the tissue in the process. This finding has implications for delaying or preventing neurodegenerative diseases by enhancing the brain's cleaning abilities.
Researchers have discovered that certain volatile compounds emitted by microbes and food can alter epigenetic states in neurons and other eukaryotic cells. Exposure to these compounds can slow down neurodegeneration and cancer, while also affecting plant growth and responses to stress.
Scientists developed an innovative neural cell culture model that replicates the aberrant behavior of TDP-43 in neurons. The model identified NPTX2 as a toxic protein that accumulates in cells containing abnormal TDP-43, leading to neurodegeneration in ALS and FTD.
A team at Case Western Reserve University has identified a key protein regulator that, when inhibited, can prevent the formation of harmful astrocytes. Administering medications that specifically target this protein may prevent the development of dangerous astrocytes and increase nerve cell survival in mouse models.
Researchers discover dopamine signals affect movement sequence length, shedding light on Parkinson's Disease symptoms and potential therapeutic targets. The study's findings suggest a complex role of dopamine neurons in movement, with distinct effects on movement-related and reward-related dopamine neurons.
A recent study has uncovered 145 genes crucial for genome stability, shedding light on genetic factors influencing human health over a lifespan. The research highlights the potential of SIRT inhibitors as a therapeutic pathway for cohesinopathies and other genomic disorders.
Researchers discovered that aggregates prevent silencing of stress response in brain cells, leading to cell death. A new treatment involves administering a drug to turn off the stress response and keeping SIFI turned on to clean up protein aggregates.
A new study from the University of Pennsylvania School of Veterinary Medicine sheds light on how Chronic Wasting Disease (CWD) impacts the gut microbiome, providing a potential tool for disease surveillance. Researchers found that certain types of gut bacteria can differentiate between CWD-positive and -negative deer.
Post-translational modifications on alpha-synuclein slow amyloid aggregation and protect neurons, potentially slowing disease progression. The study's findings suggest that targeting these modifications could lead to new treatments for Parkinson's disease.
In a mouse model of multiple system atrophy, alpha-synuclein overexpression induces neuroinflammation, demyelination, and neurodegeneration. IFNγ produced by infiltrating CD4+ T-cells mediates these changes. The study suggests that IFNγ is a potential future disease-modifying therapeutic target.
A novel drug principle has been successfully tested in a mouse model and brain organoids of ALS patients, preventing cell death and improving motor abilities. The discovery of the TwinF interface inhibitor FP802 offers a promising path for fighting ALS and could lead to the development of effective treatments.
Researchers connected cognitive and behavioral symptoms to protein buildup in the brain marking the disease. The study showed a clear relationship between CTE pathology and severity of cognitive and functional symptoms during life.
The American Society for Biochemistry and Molecular Biology's annual meeting features a stimulating group of high-profile speakers discussing various topics including climate change, microbial communities, and RNA regulation. The conference includes plenary sessions, award lectures, and other exciting events.
A new study maps the spatial organization of hippocampal neurons in the mouse brain, revealing previously unknown principles. The researchers created a comprehensive three-dimensional single-cell atlas of the region and its connections, which will aid in understanding the neural circuitry and underlying brain functions.
Indiana University researchers have found that nicotinamide nucleotide adenylyl transferase 2 (NMNAT2) plays a critical role in protecting the brain from aging and neurodegenerative diseases. The enzyme provides energy to axons, enabling them to carry out nerve impulses and maintain healthy function.
Researchers discovered the brain uses a process called temporal scaling to adjust processing of time, allowing for flexibility in behavior. This finding may have implications for understanding how our brains enable us to interact with the world.
Researchers from Pusan National University found a notable association between smoking and an increased risk of Amyotrophic Lateral Sclerosis (ALS), particularly among female smokers. The study revealed a dose-response relationship, with the risk peaking at moderate to heavy smoking levels.
A new study in the Canadian Medical Association Journal found that organ donations after medical assistance in dying (MAiD) represented 14% of all deceased organ donations in Quebec in 2022. The majority of donors had neurodegenerative diseases, with amyotrophic lateral sclerosis being the most common condition.
Researchers found that low-dose X-ray irradiation reduced lesion size and reversed motor deficits in TBI and ischemic stroke mice, demonstrating its potential as a therapeutic strategy. The treatment also accelerated substantial motor function recovery and promoted brain rewiring after stroke.